Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRVL9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,011,270
Award facts
- Contract value 100% obligated
- $1,011,269.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,011,269.61 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections. The contract, which is not set-aside and operates under firm fixed price terms, was awarded on September 13, 2025, with an ultimate completion date of September 15, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs through competitive contract awards with DLA and other government healthcare systems. The company's extensive portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. Dupixent is a biologic immunosuppressant medication commonly prescribed for conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis. The firm fixed price structure and compressed delivery timeline reflect the urgent medical supply requirements typical of military and federal healthcare procurement operations.
Quick answers
Who was awarded contract SPE2DB25FRVL9?
SPE2DB25FRVL9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 13, 2025.
How much is contract SPE2DB25FRVL9 worth?
The government has obligated $1,011,270 on SPE2DB25FRVL9.
Is contract SPE2DB25FRVL9 an order under another contract?
Yes. SPE2DB25FRVL9 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRVL9 competed?
The extent of competition for SPE2DB25FRVL9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award